SCHEMBL7981149

SCHEMBL7981149

CC(C)(Oc1ccc(Cl)cc1)C(=O)NNC(=O)c1ccncc1Br

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 3/20 0.56
CYP3A4 P08684 3/20 0.56
CYP2C19 P33261 3/20 0.56
CYP2C9 P11712 2/20 0.56
CYP2D6 P10635 2/20 0.56
ALDH1A1 P00352 3/20 0.50
PPARA Q07869 3/20 0.47
MAPT P10636 3/20 0.45
MEN1 O00255 1/20 0.45
KMT2A Q03164 1/20 0.45
LMNA P02545 1/20 0.43
CNR1 P21554 5/20 0.43
CNR2 P34972 3/20 0.43
POLB P06746 3/20 0.43
NPC1 O15118 1/20 0.43
ADAMTS5 Q9UNA0 1/20 0.43
USP2 O75604 2/20 0.42
KDM4E B2RXH2 1/20 0.42
HPGD P15428 1/20 0.42
TSHR P16473 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7984407 0.89 CYP1A2 (0.57) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL1418069 0.79 CYP1A2 (0.47) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL7981140 0.73 NPC1 (0.55) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221613 0.71 ALDH1A1 (0.59) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221608 0.70 TLR7 (0.60) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221610 0.70 PPARA (0.64) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221486 0.69 PPARA (0.58) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221607 0.69 TLR7 (0.57) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL22221587 0.69 PPARA (0.65) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6
SCHEMBL23903287 0.68 ALDH1A1 (0.57) CYP1A2CYP3A4CYP2C19CYP2C9CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377923-B2 Triazole derivative or salt thereof ASTELLAS PHARMA INC. (JP) 2013-02-19 US disclosed
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF ASTELLAS PHARMA INC. (JP) 2011-05-05 US disclosed
EP-2298747-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF Astellas Pharma Inc. (JP) 2011-03-23 EP disclosed
WO-2010001946-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF アステラス製薬株式会社 (JP) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110105460-A1 TRIAZOLE DERIVATIVE OR SALT THEREOF HSD11B1, HSD11B2, HSD3B1 CYP1A2 320/4885CYP3A4 386/4885CYP2C19 215/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.